SEC Filings TLDR

Patria Investments Limited reported its unaudited condensed consolidated interim financial statements for the three-month period ended March 31, 2025. The company, a private markets investment firm, showed a net income of $16.6 million, up from $15.9 million in the same period last year. Total assets increased to $1.33...

On July 31, 2025, Oxford Square Capital Corp. entered into an underwriting agreement with Lucid Capital Markets, LLC for the issuance and sale of $65 million aggregate principal amount of its 7.75% Notes due 2030. The offering includes an option for underwriters to purchase up to an additional $9.75 million in notes. T...

On July 31, 2025, Oxford Square Capital Corp. entered into an underwriting agreement with Lucid Capital Markets, LLC for the issuance and sale of $65 million aggregate principal amount of its 7.75% Notes due 2030. The offering includes an option for the underwriters to purchase up to an additional $9.75 million in note...

On July 31, 2025, Oxford Square Capital Corp. entered into an underwriting agreement with Lucid Capital Markets, LLC for the issuance and sale of $65 million aggregate principal amount of its 7.75% Notes due 2030. The offering includes an option for underwriters to purchase an additional $9.75 million in notes. The not...

Opendoor Technologies Inc. announced that it has regained compliance with the Nasdaq Global Select Market's minimum bid price requirement. The company received written notice from Nasdaq confirming that its common stock maintained a closing bid price of at least $1.00 for 12 consecutive business days from July 15 to Ju...

Ondas Holdings Inc. announced the appointment of Brigadier General (Ret.) Yaniv Rotem to the Advisory Board of its subsidiary, Ondas Autonomous Systems (OAS). Mr. Rotem, former Head of Military R&D at Israel’s Ministry of Defense, brings extensive experience in defense innovation, including air defense, laser systems, ...

Odyssey Marine Exploration, Inc. reported significant equity transactions in its Form 8-K filing. On July 28, 29, and 31, 2025, investors converted $1,000,000 of indebtedness under the March 2023 Notes into 909,090 shares of the company’s common stock. Additionally, investors elected to purchase 4,018,033 shares of com...

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) announced that it will report its third quarter fiscal 2025 earnings results on August 13, 2025. The company, which is Canada's leading cannabis company by market share, will host a conference call at 8:00 am Eastern Time on the same day to discuss the results. Participan...

Oculis Holding AG entered into an amended and restated loan facility agreement with Kreos Capital VII (UK) Limited on July 31, 2025. The agreement provides a borrowing capacity of up to CHF 75.0 million, which can be increased to CHF 100.0 million. The loan is structured into three tranches of CHF 25.0 million each, wi...

Ocugen, Inc. reported its second quarter 2025 financial results and provided a business update. The company announced progress in its clinical trials, including the initiation of dosing in the OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trial for Stargardt disease. Additionally, Ocugen is actively dosing ...

Oak Woods Acquisition Corporation (the Company) has extended the deadline to complete its initial business combination until August 28, 2025. This extension is the fifth of six one-month extensions permitted under the March 20, 2025 vote of the Company's shareholders, which amended the Company’s Amended and Restated Me...

Nexstar Media Group, Inc. announced that its Board of Directors has declared a quarterly cash dividend of $1.86 per share on its outstanding common stock. The dividend is payable on August 29, 2025, to stockholders of record on August 15, 2025. The company intends to pay regular quarterly cash dividends in the future, ...

NexGel, Inc. (the "Company") has entered into subscription agreements to sell and issue 413,044 shares of common stock at $2.30 per share in a registered direct offering and unregistered warrants to purchase up to 206,522 shares of common stock at an exercise price of $4.25 per share in a concurrent private placement. ...

News Corporation has filed an 8-K form with the SEC, providing an update on its stock repurchase programs. The company is authorized to acquire up to $1 billion in aggregate of its outstanding Class A and Class B common stock under the 2021 Repurchase Program and an additional $1 billion under the 2025 Repurchase Progr...

News Corporation has provided updates on its stock repurchase programs, which were initially authorized in 2021 and expanded in 2025. The company is authorized to repurchase up to $1 billion in aggregate of its Class A and Class B common stock under each program. The repurchases are subject to market conditions, the ma...

Newell Brands Inc. reported its second quarter 2025 financial results, showing a decline in net sales by 4.8% to $1.9 billion compared to the prior year period. The company achieved its eighth consecutive quarter of gross margin expansion, reaching 35.4%, up from 34.4% in the previous year. Operating margin improved to...

NeOnc Technologies Holdings, Inc. has entered into a definitive agreement with Quazar Investment for a $50 million strategic partnership, which includes the acquisition of 1.4 million shares of NeOnc at $25 per share. The partnership aims to accelerate global expansion and scientific innovation, with $15 million earmar...

Nortech Systems Incorporated has amended its $15 million senior secured revolving line of credit with Bank of America, N.A., extending the expiration date to August 31, 2026. This amendment, effective as of July 29, 2025, modifies the Credit Agreement dated February 29, 2024. The amendment includes changes to the defin...

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) provided a business update and financial results for the first half of 2025. The company is advancing its investigational combination therapy, PrimeC, for amyotrophic lateral sclerosis (ALS) through regulatory pathways and preparing for a pivotal Phase 3 trial. Key highlights...

On July 28, 2025, INVO Fertility, Inc. reported the unregistered sale of equity securities. An institutional investor and existing holder of Series C-2 Convertible Preferred Stock exercised its Additional Investment Right to acquire 200 shares of C-2 Preferred, with an aggregate stated value of $200,000, for $200,000 i...

On July 29, 2025, Carl T. (Pat) Schultz ceased to be employed as Chief Financial Officer of Microvast Holdings, Inc. The filing, submitted on Form 8-K, provides details of this significant change in the company's executive leadership. Microvast Holdings, Inc., a Delaware corporation, is listed on the NASDAQ Stock Marke...

Moderna, Inc. reported its financial results for the second quarter of 2025, with revenues of $142 million, a 41% decrease from the same period in 2024. The company announced a GAAP net loss of $(0.8) billion and a GAAP EPS of $(2.13). Moderna updated its 2025 projected revenue range to $1.5 to $2.2 billion, reflecting...

GGCP, Inc. and its affiliates, including GAMCO Investors, Inc., Gabelli Funds, LLC, and others, have filed a Schedule 13D indicating their investment in Monro, Inc. The filing reports that the group collectively owns 1,502,130 shares of Monro's common stock, representing 5.01% of the outstanding shares. The shares were...

On July 30, 2025, MediciNova, Inc. entered into a Standby Equity Purchase Agreement with YA II PN, LTD. Under this agreement, MediciNova has the right to sell up to $30 million of its common stock to Yorkville over a 36-month period. The shares will be purchased at 97% of the lowest of the three daily volume-weighted a...

On July 29, 2025, MercadoLibre, Inc.'s Board of Directors approved a Compensation Plan for Independent Directors, which includes a cash retainer fee of $90,000 and an equity award grant valued at $150,000 per year. The equity awards can be in the form of restricted stock or restricted stock units, with vesting conditio...